Rare diseases
Investigational molecules
Locations
Back to Romania322 clinical trials in Craiova, Romania across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in RomaniaStudii.Clinice.ro(opens in a new tab)Study on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors
RomaniaStudy on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis
RomaniaStudy on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation
RomaniaStudy of LY3537982, pembrolizumab, and a drug combination for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
RomaniaPhase 2 Study of Imzokitug with drug combination as First‑Line Treatment for Adults with Locally Advanced or Metastatic Non‑Small Cell Lung Cancer (NSCLC)
RomaniaEfficacy, safety and dose‑response of once‑weekly subcutaneous UBT251 compared with semaglutide in adults with type 2 diabetes
RomaniaLong‑term Safety of Adagrasib with Drug Combination in Adults with Solid Tumors
RomaniaA Randomized Double‑Blind Study of Pharmacokinetic Similarity of AVT32‑DRL_PB and Pembrolizumab in Patients with Resected Stage IIB‑C‑III Melanoma
RomaniaPhase 3 Study of GSK6042981 versus Imatinib in Adults with Previously Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors (GIST)
RomaniaStudy of Three Doses of Frevecitinib (KN-002) in Adults with Severe Asthma Not Controlled by Medium‑to‑High Dose Inhaled Steroid/LABA Therapy
RomaniaEffect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)
RomaniaEfficacy and Safety of Depemokimab for Early Intervention in Adults and Adolescents with Type 2 Asthma at Risk of Exacerbations
RomaniaThe busiest research cities in the country
What the registry says about research in the country
Current trials focus on innovative treatments for pulmonary conditions, including investigations into new therapies for asthma and pulmonary fibrosis. Research evaluates medication effectiveness in improving lung function and breathing capacity.
Studies incorporate both targeted therapies and combination treatments to address various stages of respiratory diseases.
Groundbreaking research in cancer treatment explores novel therapeutic approaches for various types of cancer, with particular focus on gastric, prostate, and lung cancers.
Trials evaluate combination therapies and immunotherapy approaches for improved patient outcomes.
Studies focus on preventing and treating heart failure and related conditions, with innovative approaches to cardiovascular disease management and metabolic disorders.
Research emphasizes both preventive strategies and treatment interventions for cardiovascular conditions.
Advanced research in autoimmune conditions and inflammatory disorders, investigating new therapeutic options for various immune-mediated diseases.
Studies evaluate both targeted therapies and broader immunological approaches.
Innovative research addressing neurological disorders and mental health conditions, with focus on both therapeutic interventions and disease management.
Trials explore novel treatment approaches for complex neurological and psychiatric conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
